---
source_path: H05CAR-PDF-ENG.md
pages: n/a-n/a
chunk_id: 8b6a957b288a1f57ebc4c6fa95f4775fd3f61dac
title: H05CAR-PDF-ENG
---
# patients.

Yamada held discussions with his research staﬀ and quickly learned

that he was not alone in his opposition to the lawsuit. The team wanted

to be a part of the solution to global health issues, not party to a lawsuit

preventing such drugs from reaching those in dire need, but they felt

they lacked the power to change the company’s direction. Yamada felt
